In addition, expression of SLAMF7 has also been identified on tumor cells in a subset of patients with chronic lymphocytic leukemia, myelodysplastic syndrome, diffuse large B cell lymphoma, and peripheral T cell lymphoma. This evidence concerns the gene SLAMF7 and peripheral T-cell lymphoma, not otherwise specified.